1. Home
  2. RDVT vs AMPH Comparison

RDVT vs AMPH Comparison

Compare RDVT & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Red Violet Inc.

RDVT

Red Violet Inc.

HOLD

Current Price

$60.86

Market Cap

920.0M

Sector

Technology

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$18.72

Market Cap

885.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDVT
AMPH
Founded
2017
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
920.0M
885.4M
IPO Year
2017
2005

Fundamental Metrics

Financial Performance
Metric
RDVT
AMPH
Price
$60.86
$18.72
Analyst Decision
Strong Buy
Buy
Analyst Count
1
8
Target Price
$62.00
$28.38
AVG Volume (30 Days)
172.3K
421.7K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
82.00
N/A
EPS
0.30
0.14
Revenue
$90,252,000.00
$719,887,000.00
Revenue This Year
$16.31
$6.90
Revenue Next Year
$13.83
$4.64
P/E Ratio
$198.57
$134.79
Revenue Growth
20.03
N/A
52 Week Low
$33.40
$16.65
52 Week High
$69.65
$31.26

Technical Indicators

Market Signals
Indicator
RDVT
AMPH
Relative Strength Index (RSI) 48.27 44.70
Support Level $51.49 $18.92
Resistance Level $64.14 $19.99
Average True Range (ATR) 2.61 0.69
MACD -1.19 -0.06
Stochastic Oscillator 27.10 27.58

Price Performance

Historical Comparison
RDVT
AMPH

About RDVT Red Violet Inc.

Red Violet Inc builds proprietary technologies and applies analytical capabilities to deliver identity intelligence. The company's solutions enable the real-time identification and location of people, businesses, assets, and their interrelationships. These solutions are used for purposes including identity verification, risk mitigation, due diligence, fraud detection and prevention, regulatory compliance, and customer acquisition. Its cloud-native, AI-enabled identity intelligence platform, CORE, is purpose-built for the enterprise, yet flexible enough for organizations of all sizes, bringing clarity to massive datasets by transforming data into intelligence. The company generates substantially all of its revenue from licensing its solutions.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: